Latest News On Clinical Trials

Latest California Healthline Stories

Despite Failed Promises, Stem Cell Advocates Again Want Taxpayers To Pony Up Billions

California’s stem cell agency, created by a $3 billion bond measure 15 years ago, is almost out of money. Its supporters plan to ask voters for even more funding next year, even though no agency-funded treatments have been approved for widespread use.

FDA Overlooked Red Flags In Drugmaker’s Testing of New Depression Medicine

In March, a chemical cousin of the anesthetic and club drug ketamine was approved for the treatment of patients with intractable depression. But critics say studies presented to the FDA provided at best modest evidence it worked and did not include information about the safety of the drug, Spravato, for long-term use.

Choosing Between Death And Deportation

What happens when an undocumented immigrant has a life-threatening diagnosis? Much depends on where the person lives. And even in states with generous care for a dire illness, a patient can face difficult life-and-death choices.

University Under Fire For Off-The-Grid Herpes Vaccine Experiments

Southern Illinois University’s ethics panel launches “full” inquiry into herpes vaccine experiments on human subjects that took place offshore and in the U.S. without proper oversight by one of its professors, who has since died.